204 related articles for article (PubMed ID: 16788694)
1. Effect of mycophenolate mofetil on rat kidney grafts with prolonged cold preservation.
Fuller TF; Hoff U; Rose F; Linde Y; Freise CE; Dragun D; Feng S
Kidney Int; 2006 Aug; 70(3):570-7. PubMed ID: 16788694
[TBL] [Abstract][Full Text] [Related]
2. Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeyoshi I; Morishita Y; Kobayashi E
Transpl Immunol; 2004 Nov; 13(3):219-27. PubMed ID: 15381205
[TBL] [Abstract][Full Text] [Related]
3. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury.
Ysebaert DK; De Greef KE; Vercauteren SR; Verhulst A; Kockx M; Verpooten GA; De Broe ME
Kidney Int; 2003 Sep; 64(3):864-73. PubMed ID: 12911536
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats.
Romero F; Rodríguez-Iturbe B; Parra G; González L; Herrera-Acosta J; Tapia E
Kidney Int; 1999 Mar; 55(3):945-55. PubMed ID: 10027931
[TBL] [Abstract][Full Text] [Related]
5. [Effects of mycophenolate mofetil in ischemic acute renal failure in rats].
Chávez-Velásquez M; Pons H; Medina M; Quiroz Y; Parra G; Herrera J
Nefrologia; 2007; 27(4):448-58. PubMed ID: 17944582
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury.
Jiang S; Tang Q; Rong R; Tang L; Xu M; Lu J; Jia Y; Ooi Y; Hou J; Guo J; Yang B; Zhu T
Eur J Pharmacol; 2012 Aug; 688(1-3):56-61. PubMed ID: 22609232
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil inhibits regenerative repair in uranyl acetate-induced acute renal failure by reduced interstitial cellular response.
Sun DF; Fujigaki Y; Fujimoto T; Goto T; Yonemura K; Hishida A
Am J Pathol; 2002 Jul; 161(1):217-27. PubMed ID: 12107106
[TBL] [Abstract][Full Text] [Related]
8. Effects of mycophenolic acid mofetil on acute rejection of kidney allografts in rats.
Heemann U; Azuma H; Schmid C; Philipp T; Tilney N
Clin Nephrol; 1996 May; 45(5):355-7. PubMed ID: 8738672
[TBL] [Abstract][Full Text] [Related]
9. Distinct effects of mycophenolate mofetil and cyclophosphamide on renal fibrosis in NZBWF1/J mice.
Yung S; Zhang Q; Chau MK; Chan TM
Autoimmunity; 2015; 48(7):471-87. PubMed ID: 26099989
[TBL] [Abstract][Full Text] [Related]
10. 15-Deoxyspergualin and cyclophosphamide, but not mycophenolate mofetil, prolong survival and attenuate renal disease in a murine model of ANCA-associated crescentic nephritis.
Birck R; Newman M; Braun C; Neumann I; Nemoto K; Yard B; Waldherr R; van der Woude FJ
Nephrol Dial Transplant; 2006 Jan; 21(1):58-63. PubMed ID: 16141461
[TBL] [Abstract][Full Text] [Related]
11. Glutamine donor pretreatment in rat kidney transplants with severe preservation reperfusion injury.
Fuller TF; Rose F; Singleton KD; Linde Y; Hoff U; Freise CE; Dragun D; Niemann CU
J Surg Res; 2007 Jun; 140(1):77-83. PubMed ID: 17292409
[TBL] [Abstract][Full Text] [Related]
12. Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation.
Lobb I; Mok A; Lan Z; Liu W; Garcia B; Sener A
BJU Int; 2012 Dec; 110(11 Pt C):E1187-95. PubMed ID: 23157304
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
[TBL] [Abstract][Full Text] [Related]
14. Cytoprotective Actions of FTY720 Modulate Severe Preservation Reperfusion Injury in Rat Renal Transplants.
Fuller TF; Hoff U; Kong L; Naether M; Wagner P; Nieminen-Kelhä M; Nolting J; Luft FC; Hegner B; Dragun D
Transplantation; 2010 Feb; 89(4):402-8. PubMed ID: 20177341
[TBL] [Abstract][Full Text] [Related]
15. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.
Klupp J; van Gelder T; Dambrin C; Regieli JJ; Boeke K; Billingham ME; Morris RE
J Heart Lung Transplant; 2004 Mar; 23(3):334-51. PubMed ID: 15019644
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil attenuates renal ischemia/reperfusion injury.
Ventura CG; Coimbra TM; de Campos SB; de Castro I; Yu L; Seguro AC
J Am Soc Nephrol; 2002 Oct; 13(10):2524-33. PubMed ID: 12239241
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment.
Hutchinson P; Jose M; Atkins RC; Holdsworth SR
Transpl Immunol; 2004; 13(1):55-61. PubMed ID: 15203129
[TBL] [Abstract][Full Text] [Related]
19. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney.
Badid C; Vincent M; McGregor B; Melin M; Hadj-Aissa A; Veysseyre C; Hartmann DJ; Desmouliere A; Laville M
Kidney Int; 2000 Jul; 58(1):51-61. PubMed ID: 10886549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
